BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 23461369)

  • 1. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
    Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V
    Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
    Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
    Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
    Kang SW; Park SC; Cho HY; Kang JH
    Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
    Figueroa MS; Contreras I; Noval S
    Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
    Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
    Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T; Uemura A; Kita H; Sakamoto T
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
    Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
    Sevim MS; Sanisoglu H; Turkyilmaz K
    Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
    DeCroos FC; Shuler RK; Stinnett S; Fekrat S
    Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of visual acuity and central macular thickness after vitrectomy for diffuse diabetic macular edema with or without preoperative treatments].
    Nizawa T; Arai M; Takatsuna Y; Oshitari T; Sato E; Yamamoto S
    Nippon Ganka Gakkai Zasshi; 2013 Oct; 117(10):785-92. PubMed ID: 24354262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular edema following cataract surgery in eyes with previous 23-gauge vitrectomy and peeling of the internal limiting membrane.
    Mylonas G; Sacu S; Deák G; Dunavoelgyi R; Buehl W; Georgopoulos M; Schmidt-Erfurth U;
    Am J Ophthalmol; 2013 Feb; 155(2):253-259.e2. PubMed ID: 23036567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.